We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

69 hedge funds and large institutions have $101M invested in Corbus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

28% more funds holding

Funds holding: 54 → 69 (+15)

0.1% more ownership

Funds ownership: 0.96% → 1.06% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less capital invested

Capital invested by funds: $116M → $101M (-$15M)

19% less call options, than puts

Call options by funds: $2.19M | Put options by funds: $2.71M

Holders
69
Holders Change
+15
Holders Change %
+27.78%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
18
Reduced
4
Closed
18
Calls
$2.19M
Puts
$2.71M
Net Calls
-$518K
Net Calls Change
+$1.73M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$11.7M
2
State Street
State Street
Massachusetts
+$3.72M
3
Northern Trust
Northern Trust
Illinois
+$2.81M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.01M
5
AG
Artal Group
Luxembourg
+$1.63M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$13.9M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.02M
3
EI
EAM Investors
California
-$1.29M
4
VKH
Virtu KCG Holdings
New York
-$1.17M
5
RJA
Raymond James & Associates
Florida
-$1.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$23.6M – – –
BlackRock
2
BlackRock
New York
$15.5M +$11.7M +59,726 +269%
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.85M +$2.01M +10,266 +25%
PA
4
Perceptive Advisors
New York
$7.76M -$115K -584 -1%
IA
5
IFP Advisors
Florida
$6.31M – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$5.78M -$187K -953 -3%
Millennium Management
7
Millennium Management
New York
$4.41M +$311K +1,587 +7%
State Street
8
State Street
Massachusetts
$3.71M +$3.72M +18,989 +3,000%
Northern Trust
9
Northern Trust
Illinois
$3.04M +$2.81M +14,320 +815%
RJFSA
10
Raymond James Financial Services Advisors
Florida
$2.69M +$146K +746 +6%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.78M +$534K +2,723 +41%
AG
12
Artal Group
Luxembourg
$1.57M +$1.63M +8,333 New
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$1.19M +$1.24M +6,302 New
Creative Planning
14
Creative Planning
Kansas
$1.09M +$42.7K +218 +4%
Deutsche Bank
15
Deutsche Bank
Germany
$952K +$335K +1,708 +51%
CIBC Private Wealth Group
16
CIBC Private Wealth Group
Georgia
$904K – – –
Bank of New York Mellon
17
Bank of New York Mellon
New York
$862K +$756K +3,857 +549%
BBA
18
Baker Bros. Advisors
New York
$820K – – –
Allianz Asset Management
19
Allianz Asset Management
Germany
$761K +$190K +968 +32%
TCIM
20
TIAA CREF Investment Management
New York
$760K +$788K +4,019 New
Morgan Stanley
21
Morgan Stanley
New York
$686K +$197K +1,004 +38%
TA
22
Teachers Advisors
New York
$503K +$521K +2,659 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$495K +$513K +2,617 New
Charles Schwab
24
Charles Schwab
California
$469K +$486K +2,477 New
HCM
25
Highbridge Capital Management
New York
$464K – – –
1
2 3 4

CRBP Hedge Fund Activity: Q2 2017 in Review

69 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q2 2017, worth a combined $101M — down 13% from $116M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new CRBP positions and 18 closed out — a net gain of 15 holders — while 18 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $11.7M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $13.9M sold.

  • 69 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q2 2017, up from 54 in Q1 2017.
  • Funds reported $101M of Corbus Pharmaceuticals stock for Q2 2017, down 13% quarter-over-quarter.
  • 33 funds opened new Corbus Pharmaceuticals positions in Q2 2017 and 18 closed out, a net change of +15 holders.
  • The largest Corbus Pharmaceuticals buyer in Q2 2017 was BlackRock, an estimated $11.7M added.
  • The largest Corbus Pharmaceuticals seller in Q2 2017 was Cormorant Asset Management, an estimated $13.9M sold.

Based on aggregated 13F filings for Q2 2017.